Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients

Endocrine

Volumn 45, Issue 1, 2014, Pages 114-121

  Dogan, Serkan ^a   Atmaca, Aysegul ^a,b   Dagdelen, Selcuk ^a   Erbas, Belkis ^a   Erbas, Tomris ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acromegaly; Growth hormone; Insulin like growth factor 1; Thyroid cancer; Thyroid nodules

Indexed keywords

AMIODARONE;

ACROMEGALY; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE DURATION; ECHOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NODULAR GOITER; ONCOCYTOMA; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FUNCTION TEST; THYROID NODULE; THYROID SCINTISCANNING; THYROID WEIGHT; THYROTOXICOSIS; TOXIC GOITER;

ACROMEGALY; ADOLESCENT; ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84895903673     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9981-3     Document Type: Article

References (41)

1. S. Melmed, Acromegaly. N. Engl. J. Med. 322, 966-967 (1990)
2. A. Fernandez, N. Karavitaki, J.A.H. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxforshire, UK). Clin. Endocrinol. 72, 377-382 (2010)
3. L. Alexander, D. Appleton, R. Hall, W.M. Ross, R. Wilkinson, Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol. 12, 71-79 (1980)
4. J.D. Nabarro, Acromegaly. Clin. Endocrinol. 26, 481-512 (1987)
5. A. Abosch, J.B. Tyrrell, K.R. Lamborn, L.T. Hannegan, C.B. Applebury, C.B. Wilson, Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J. Clin. Endocrinol. Metab. 83, 3411-3418 (1988)
6. S.M. Orme, R.J. McNally, R.A. Cartwright, P.E. Belchetz, Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J. Clin. Endocrinol. Metab. 83, 2730-2734 (1998)
7. B. Swearingen, F.G. Barker 2nd, L. Katznelson, B.M. Biller, S. Grinspoon, A. Klibanski, N. Moayeri, P.M. Black, N.T. Zervas, Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83, 3419-3426 (1998)
8. I. Klein, G. Parveen, J.S. Gavaler, D.H. Vanthiel, Colonic polyps in patients with acromegaly. Ann. Intern. Med. 97, 27-30 (1982)
9. J. Barzilay, G.J. Heatley, G.W. Cushing, Benign and malignant tumors in patients with acromegaly. Arch. Intern. Med. 151, 1629-1632 (1991)
10. S. Ezzat, S. Melmed, Are patients with acromegaly at increased risk for neoplasia? J. Clin. Endocrinol. Metab. 72, 245-249 (1991)
11. E. Ron, G. Gridley, Z. Hrubec, W. Page, S. Arora, J.F. Fraumeni Jr, Acromegaly and gastrointestinal cancer. Cancer 1991(68), 1673-1677 (1991)
12. V. Popovic, S. Damjanovic, D. Micic, M. Nesovic, M. Djurovic, M. Petakov, S. Obradovic, S. Zoric, M. Simic, Z. Penezic, J. Marinkovic, Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin. Endocrinol. 49, 441-445 (1998)
13. Y. Higuchi, N. Saeki, T. Iuchi, Y. Uchino, I. Tatsuno, D. Uchida, T. Tanaka, Y. Noguchi, S. Nakamura, T. Yasuda, A. Yamaura, K. Sunami, Y. Oka, A. Uozumi, Incidence of malignant tumors in patients with acromegaly. Endocr. J. 47, S57-S60 (2000)
14. P.J. Jenkins, M. Besser, Clinical perspective: acromegaly and cancer: a problem. J. Clin. Endocrinol. Metab. 86, 2935-2941 (2001)
15. A. Wolk, The growth hormone and insulin-like growth factor I axis, and cancer. Lancet 363, 1336-1337 (2004)
16. S. Melmed, F.F. Casanueva, F. Cavagnini, P. Chanson, L. Frohman, A. Grossman, K. Ho, D. Kleinberg, S. Lamberts, E. Laws, G. Lombardi, M.L. Vance, K.V. Werder, J. Wass, A. Giustina, Acromegaly Treatment Consensus Workshop Participants, Guidelines for acromegaly management. J. Clin. Endocrinol. Metab. 87, 4054-4058 (2002)
17. A. Rogozinski, A. Furioso, P. Glikman, M. Junco, R. Laudi, A. Reyes, A. Lowenstein, Thyroid nodules in acromegaly. Arq. Bras. Endocrinol. Metab. 56, 300-304 (2012)
18. G. Siegel, Y. Tomer, Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Endocr. Res. 31, 51-58 (2005)
19. D. Baris, G. Gridley, E. Ron, E. Weiderpass, L. Mellemkjaer, A. Ekbom, J.H. Olsen, J.A. Baron, J.F. Fraumeni Jr, Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13, 395-400 (2002)
20. C. Balkany, G.W. Cushing, An association between acromegaly and thyroid carcinoma. Thyroid 5, 47-50 (1995)
21. M.C.C. Dos Santos, G.C. Nascimento, A.G.C. Nascimento, V.C. Carvalho, M.H.C. Lopes, R. Montenegro, R. Montenegro Jr, L. Vilar, M.F. Albano, A.R.V. Alves, C.V. Parente, M. Dos Santos Faria, Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16, 109-114 (2013)
22. B.L. Herrmann, H. Baumann, O.E. Janssen, R. Gorges, K.W. Schmid, K. Mann, Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp. Clin. Endocrinol. Diabetes 112, 225-230 (2004)
23. P. Tita, M.R. Ambrosio, C. Scollo, A. Carta, P. Gangemi, M. Bondanelli, R. Vigneri, E.C. degli Uberti, V. Pezzino, High prevalence of differentiated thyroid carcinoma in acromegaly. Clin. Endocrinol. 63, 161-167 (2005)
24. A. Baldys-Waligorska, A. Krzentowska, F. Golkowski, G. Sokolowski, A. Hubalewska-Dydejczyk, The prevalence of benign and malignant neoplasms in acromegalic patients. Endokrynol. Pol. 61, 29-34 (2010)
25. B.E. Gullu, O. Celik, N. Gazioglu, P. Kadioglu, Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13, 242-248 (2010)
26. A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526-529 (2000)
27. P. Vitti, T. Rago, S. Mazzeo, S. Brogioni, M. Lampis, A. De Liperi, C. Bartolozzi, A. Pinchera, E. Martino, Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. J. Endocrinol. Invest. 18, 857-861 (1995)
28. S. Loeper, S. Ezzat, Acromegaly: re-thinking cancer risk. Rev. Endocr. Metab. Disord. 9, 41-58 (2008)
29. M. Kurimoto, I. Fukuda, N. Hizuka, K. Takano, The prevalence of benign and malignant tumors in patients with acromegaly. Endocr. J. 55, 67-71 (2008)
30. S. Eser, C. Yakut, R. Özdemir, H. Karakilinç, S. Özalan, S.F. Marshall, O. Karaoǧlanoǧlu, Z. Anbarcioǧlu, N. Üçüncü, Ü. Akin, E. Özen, N. Özgül, H. Anton-Culver, M. Tuncer, Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac. J. Cancer Prev 11, 1731-1739 (2010)
31. M. Scacchi, M. Andrioli, C. Carzaniga, G. Vitale, M. Moro, L. Poggi, F.P. Giraldi, L.M. Fatti, F. Cavagnini, Elastosonographic evaluation of thyroid nodules in acromegaly. Eur. J. Endocrinol. 161, 607-613 (2009)
32. M. Andrioli, M. Scacchi, C. Carzaniga, G. Vitale, M. Moro, L. Poggi, L.M. Fatti, F. Cavagnini, Thyroid nodules in acromegaly: the role of elastography. J. Ultrasound 13, 90-97 (2010)
33. N.W. Cheung, S.C. Boyages, The thyroid gland in acromegaly: an ultrasonographic study. Clin. Endocrinol. 46, 545-549 (1997)
34. M. Miyakawa, M. Saji, T. Tsushima, K. Wakai, K. Shizume, Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor 1 levels. J. Clin. Endocrinol. Metab. 67, 973-978 (1988)
35. C. Wuster, G. Steger, A. Schmelzle, J. Gottswinter, H.W. Minne, R. Ziegler, Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm. Metab. Res. 1991(23), 131-134 (1991)
36. D. Tramontano, G.W. Cushing, A.C. Moses, S.H. Ingbar, Insulin-like growth factor stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology 119, 940-942 (1986)
37. Y.J. Liu, W. Qiang, J. Shi, S.Q. Lv, M.J. Ji, B.Y. Shi, Expression and significance of IGF-1 and IGF-1R in thyroid nodules. Endocrine (2013). doi: 10.1007/s12020-012-9864-z
38. A.G. Renehan, Acromegaly, growth hormone and cancer risk. Best Pract. Res. Clin. Endocrinol. Metab. 22, 639-657 (2008)
39. A. Renehan, M. Tyson, M. Egger, R.F. Heller, M. Zwahlen, Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569-578 (2008)
40. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, W. Wiersinga, European thyroid cancer taskforce: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787-803 (2006)
41. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, American Thyroid Association (ATA), Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167-1214 (2009)